Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche’s Novel Ranibizumab Implant Among Myriad New Filings In EU

US Approval For Port Delivery System Expected Late 2021

Jun 11 2021

• By Neena Brizmohun

Share close up view of human eye with data illustration, robotic concept — Age-related macular degeneration usually first affects people in their 50s and 60s • Source: Alamy

Related Content

Keeping Track: US FDA Clears Another CAR-T And Another Novel ADHD Drug; Submissions Blossom

Apr 05 2021

First US Lucentis Biosimilar Expected By Year End, Roche Confirms

Apr 23 2021

Y-mAbs Faces Delay In Pediatric Neuroblastoma With Refuse-To-File Letter

Oct 06 2020

Janssen/Legend’s Cilta-Cel Responses Could Make Up For Second-To-Market Position

Jun 03 2021

Related Companies

Roche Holding AG

Novartis AG

Janssen Pharmaceutical Cos.

Legend Biotech Corp.

Ipsen SA

Oncopeptides AB

Y-mAbs Therapeutics Inc.

Neurocrine Biosciences, Inc.

Samsung Bioepis Co., Ltd.

Bristol Myers Squibb Company

Bluebird Bio

Additional Topics

Europe Drug Review Approvals Drug Delivery Technology Market Access Regulation Review Pathway Cancer Ophthalmic Orthopedics Neurology BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.